167 related articles for article (PubMed ID: 8008226)
1. The economic cost of migraine. Present state of knowledge.
de Lissovoy G; Lazarus SS
Neurology; 1994 Jun; 44(6 Suppl 4):S56-62. PubMed ID: 8008226
[TBL] [Abstract][Full Text] [Related]
2. Cost of health care among patients with chronic and episodic migraine in Canada and the USA: results from the International Burden of Migraine Study (IBMS).
Stokes M; Becker WJ; Lipton RB; Sullivan SD; Wilcox TK; Wells L; Manack A; Proskorovsky I; Gladstone J; Buse DC; Varon SF; Goadsby PJ; Blumenfeld AM
Headache; 2011; 51(7):1058-77. PubMed ID: 21762134
[TBL] [Abstract][Full Text] [Related]
3. Economic costs of diabetes in the U.S. In 2007.
American Diabetes Association
Diabetes Care; 2008 Mar; 31(3):596-615. PubMed ID: 18308683
[TBL] [Abstract][Full Text] [Related]
4. Economic burden of transformed migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study.
Munakata J; Hazard E; Serrano D; Klingman D; Rupnow MF; Tierce J; Reed M; Lipton RB
Headache; 2009 Apr; 49(4):498-508. PubMed ID: 19245386
[TBL] [Abstract][Full Text] [Related]
5. Cost of depression in Europe.
Sobocki P; Jönsson B; Angst J; Rehnberg C
J Ment Health Policy Econ; 2006 Jun; 9(2):87-98. PubMed ID: 17007486
[TBL] [Abstract][Full Text] [Related]
6. Direct cost burden among insured US employees with migraine.
Hawkins K; Wang S; Rupnow M
Headache; 2008 Apr; 48(4):553-63. PubMed ID: 18070057
[TBL] [Abstract][Full Text] [Related]
7. Impact of migraine symptoms on health care use and work loss in Canada in patients randomly assigned in a phase III clinical trial.
Lambert J; Carides GW; Meloche JP; Gerth WC; Marentette MA
Can J Clin Pharmacol; 2002; 9(3):158-64. PubMed ID: 12422253
[TBL] [Abstract][Full Text] [Related]
8. The impact of a worksite migraine intervention program on work productivity, productivity costs, and non-workplace impairment among Spanish postal service employees from an employer perspective.
Vicente-Herrero T; Burke TA; Laínez MJ
Curr Med Res Opin; 2004 Nov; 20(11):1805-14. PubMed ID: 15537481
[TBL] [Abstract][Full Text] [Related]
9. [Migraine--a burden for the individual and the society].
Demarin V; Vuković V
Acta Med Croatica; 2008 May; 62(2):137-40. PubMed ID: 18710076
[TBL] [Abstract][Full Text] [Related]
10. Migraine: epidemiology, impact, and risk factors for progression.
Lipton RB; Bigal ME
Headache; 2005 Apr; 45 Suppl 1():S3-S13. PubMed ID: 15833088
[TBL] [Abstract][Full Text] [Related]
11. The cost of migraine and its treatment.
Goldberg LD
Am J Manag Care; 2005 Jun; 11(2 Suppl):S62-7. PubMed ID: 16095269
[TBL] [Abstract][Full Text] [Related]
12. The prevalence of headache in a population of health care workers and the effects on productivity costs.
Cristofolini A; Dalla Serra P; Scherillo G; Orrico D; Micciolo R
Med Lav; 2008; 99(1):8-15. PubMed ID: 18254535
[TBL] [Abstract][Full Text] [Related]
13. The burden of illness associated with renal cell carcinoma in the United States.
Lang K; Danchenko N; Gondek K; Schwartz B; Thompson D
Urol Oncol; 2007; 25(5):368-75. PubMed ID: 17826652
[TBL] [Abstract][Full Text] [Related]
14. Economic burden of migraine in Latvia and Lithuania: direct and indirect costs.
Lublóy Á
BMC Public Health; 2019 Sep; 19(1):1242. PubMed ID: 31500616
[TBL] [Abstract][Full Text] [Related]
15. Company reference estimates for productivity loss due to migraine and productivity gains using rizatriptan 10 mg in Germany.
Yoon MS; Katsarava Z; Liedert B; Krobot KJ; Diener HC; Limmroth V
Int J Clin Pract; 2006 Mar; 60(3):295-9. PubMed ID: 16494644
[TBL] [Abstract][Full Text] [Related]
16. The economic burden of depression in 1990.
Greenberg PE; Stiglin LE; Finkelstein SN; Berndt ER
J Clin Psychiatry; 1993 Nov; 54(11):405-18. PubMed ID: 8270583
[TBL] [Abstract][Full Text] [Related]
17. [Migraine: implications for work, disability and request for health services in Colombia].
Reynales H; Aycardi E; Valencia D
Rev Neurol; 2001 Jun 1-15; 32(11):1001-5. PubMed ID: 11562818
[TBL] [Abstract][Full Text] [Related]
18. The annual impact of seasonal influenza in the US: measuring disease burden and costs.
Molinari NA; Ortega-Sanchez IR; Messonnier ML; Thompson WW; Wortley PM; Weintraub E; Bridges CB
Vaccine; 2007 Jun; 25(27):5086-96. PubMed ID: 17544181
[TBL] [Abstract][Full Text] [Related]
19. Estimating the cost of epilepsy in Europe: a review with economic modeling.
Pugliatti M; Beghi E; Forsgren L; Ekman M; Sobocki P
Epilepsia; 2007 Dec; 48(12):2224-33. PubMed ID: 18088267
[TBL] [Abstract][Full Text] [Related]
20. An assessment of the burden of migraine using the willingness to pay model.
Hamelsky SW; Lipton RB; Stewart WF
Cephalalgia; 2005 Feb; 25(2):87-100. PubMed ID: 15658945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
